Site navigation

Navigation

Radiotherapy for age-related macular degeneration

 
Guidance issued
 
IPG Number: IPG49

Summary

The National Institute for Health and Clinical Excellence (NICE) has issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on radiotherapy for age-related macular degeneration.

Description

Age-related macular degeneration is the commonest cause of irreversible blindness in developed countries. Radiotherapy can be used to destroy new vessels in the wet form of maacular degeneration. It is usually given as a day treatment. The beam of radiotherapy is angled to avoid damage to the optic nerve and structures in the other eye.

OPCS code:

Details

Arrangement:
Research Only
Topic area:
Eye
Surgical procedures
Specialty:
Geriatric medicine
Medical opthalmology
Specialist advice has been sought from:
Royal College of Ophthalmologists
Date notified to NICE:
01 April 2002
Guidance issue date:
24 March 2004

Contact details:

Project manager (for general enquiries or comments)
(for general enquiries or comments)
Ben Doak
Contact Address:

Interventional Procedures Programme
National Institute for Health and Clinical Excellence
MidCity Place
71 High Holborn
London
WC1V 6NA

Links: